Silimarina modifica a atividade da Na+/K+-ATPase e da MAO e modula a ação de antimicrobianos in vitro

• Autor(a) principal: Oliveira, Dayanne Rakelly de
• Data de Publicação: 2015
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Manancial - Repositório Digital da UFSM
• dARK ID: ark:/26339/0013000015p6t
• Texto Completo: http://repositorio.ufsm.br/handle/1/4493
• topic: Silimarina; Silibinina; Estresse oxidativo; Monoamina oxidase; Na+/K+-ATPase; Peroxidação lipídica; Concentração inibitória mínima; Modulação antimicrobiana; Silymarin; Silibinin; Oxidative stress; Monoamine oxidase; Na+/K+-ATPase; Lipid peroxidation; Minimal inhibitory concentration; Antimicrobial modulation; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA

The Silymarin is a flavonolignan complex isolated from milk thistle seeds of Silybum marianum being used in the treatment of injury related to oxidative stress, including liver and neurological diseases, as Parkinson disease. Although silymarin has been reported to possess a variety of pharmacological properties including anti-inflammatory, anticarcinogenic and neuroprotective effects, information regard its antimicrobial and drug modulator potential against microbial resistance is scanty in the literature. In addition, the possible involvement of antioxidant activity in its neuroprotective effect, and on the activity of important enzymes of the central nervous system (i.e., Na+/K+-ATPase and monoamine oxidase (MAO)) have not yet been completely elucidated. Therefore, the objective of this study was to investigate the effect of silymarin on the activity of the enzymes Na+/K+-ATPase and MAO as well as its ability in to modulate the action of antimicrobials in vitro. The results demonstrated that silymarin scavenged the DPPH (2,2-diphenyl-1-picrylhydrazyl) radical and, also reduced significantly the Fe2+ (10 μM) and SNP (sodium nitroprusside, 5 μM) induced lipid peroxidation in rat brain homogenate. Silymarin protected against the oxidation of thiol groups (protein and non-protein) induced by the pro-oxidants, and avoided the reduction in the activity of catalase caused by pro-oxidants at a concentration of 30 μg/mL. The incubation of different concentrations of silymarin increased the activity of Na+/K+-ATPase enzyme and reduced the activity of the enzymes MAO-A and MAO-B. However, the inhibition of MAO-B was more pronounced. The evaluation of the kinetic parameters demonstrated that Silymarin did not alter significantly the Km values for MAO-A and MAO-B, but caused a decrease in Vmax values for both isoforms of the enzyme. With regard to the antimicrobial activity, silymarin and its major active constituent silybin, did not demonstrate antibacterial and antifungal activities not relevant from a clinical point of view (with values of MIC - minimal inhibitory concentration- > 500 μg/mL). However, silybin showed clinically significant antibacterial activity against Escherichia coli with MIC/8 = 64 μg/mL. The combination of sylimarin and silybin demonstrated synergistic activity modulating the efficacy of antibiotics drugs (amikacin, gentamicin, ciprofloxaxin ou imipenem) or antifungal (mebendazole ou nystatin), particularly from the class of aminoglycosides, against multiresistant strains Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. However, silybin antagonized the antibacterial effect of gentamicin and imipenem against P. aeruginosa. Similarly, silymarin and silybin had antagonistic effect with nystatin against Candida albicans, Candida tropicalis and Candida kruzei. In conclusion, the results showed that silymarin alters the activities of Na+/K+-ATPase and monoamine oxidase, indicating that its neuroprotective effect is not only associated to its antioxidant capacity. The potential of silymarin and silybin to modulate the effects of the drugs suggests an alternative to control bacterial infections caused by antibiotics resistance.